Cargando…

Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial

AIMS: The AleCardio trial aimed to characterize the efficacy and safety of peroxisome proliferator‐activated receptor‐αγ agonist aleglitazar in patients with type 2 diabetes mellitus and acute coronary syndrome. The trial terminated early because of futility and safety signals. We evaluated whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koomen, Jeroen V., Heerspink, Hiddo J. L., Schrieks, Ilse C., Schwartz, Gregory G., Lincoff, A. Michael, Nicholls, Stephen J., Svensson, Anders, Wedel, Hans, Weichert, Arlette, Grobbee, Diederick E., Stevens, Jasper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916612/ https://www.ncbi.nlm.nih.gov/pubmed/31468659 http://dx.doi.org/10.1111/dom.13862

Ejemplares similares

Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
por: Grobbee, Esmée J., et al.
Publicado: (2022)

Exposure–response relationships of dapagliflozin on cardiorenal risk markers and adverse events: A pooled analysis of 13 phase II/III trials
por: Koomen, Jeroen V., et al.
Publicado: (2020)

Analysis of Ale
Publicado: (1875)

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe
por: Koomen, Jeroen V., et al.
Publicado: (2021)

Determining the optimal dose of atrasentan by evaluating the exposure‐response relationships of albuminuria and bodyweight
por: Koomen, Jeroen V., et al.
Publicado: (2018)

The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders
por: Schievink, Bauke, et al.
Publicado: (2014)

Worthington's Ales
Publicado: (1906)

Exposure–response relationships for the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin with regard to renal risk markers
por: Kroonen, Marjolein Y. A. M., et al.
Publicado: (2020)

Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study
por: Ruilope, Luis, et al.
Publicado: (2014)

Improving clinical trial efficiency by biomarker-guided patient selection
por: Boessen, Ruud, et al.
Publicado: (2014)

An ALE Meta-Analysis on Investment Decision-Making
por: Ortiz-Teran, Elena, et al.
Publicado: (2021)

Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors
por: Dietz, Michel, et al.
Publicado: (2012)

Cakes and ale ; or, The skeleton in the cupboard
por: Maugham, W. Somerset (William Somerset), 1874-1965
Publicado: (1948)

The neural basis of audiomotor entrainment: an ALE meta-analysis
por: Chauvigné, Léa A. S., et al.
Publicado: (2014)

Cultural Differences in Inhibitory Control: An ALE Meta-Analysis
por: Gavazzi, Gioele, et al.
Publicado: (2023)

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
por: Heerspink, Hiddo J Lambers, et al.
Publicado: (2009)

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
por: van der Hoek, Sjoukje, et al.
Publicado: (2023)

Coordinate-based (ALE) meta-analysis of acupuncture for musculoskeletal pain
por: Ha, Guodong, et al.
Publicado: (2022)

Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial
por: Mohebi, Reza, et al.
Publicado: (2023)

Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice
por: Boujon, Valérie, et al.
Publicado: (2019)

Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia
por: Chen, Yan, et al.
Publicado: (2017)

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin
por: Kroonen, Marjolein Y. A. M., et al.
Publicado: (2019)

Cerebellar contributions to visuomotor adaptation and motor sequence learning: an ALE meta-analysis
por: Bernard, Jessica A., et al.
Publicado: (2013)

Brain networks of perceptual decision-making: an fMRI ALE meta-analysis
por: Keuken, Max C., et al.
Publicado: (2014)

Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis
por: Zhang, Bei, et al.
Publicado: (2015)

ALE meta‐analysis reveals dissociable networks for affective and discriminative aspects of touch
por: Morrison, India
Publicado: (2016)

Separate Neural Systems Value Prosocial Behaviors and Reward: An ALE Meta-Analysis
por: Wang, Haixia, et al.
Publicado: (2019)

Properties of cross-modal occipital responses in early blindness: An ALE meta-analysis
por: Zhang, Caiyun, et al.
Publicado: (2019)

Functional neuroanatomy of language without speech: An ALE meta‐analysis of sign language
por: Trettenbrein, Patrick C., et al.
Publicado: (2020)

Reinvestigating the Neural Bases Involved in Speech Production of Stutterers: An ALE Meta-Analysis
por: Zhang, Ning, et al.
Publicado: (2022)

Anti-explosion performance analysis of marine interdiction system based on ALE method
por: Liu, Zeping, et al.
Publicado: (2023)

La poétique du m{circ}ale
por: Coquillat, Michelle
Publicado: (1982)

Exceptional SW Geometry from ALE Fibrations
por: Lerche, W., et al.
Publicado: (1996)

Implicaţii psihosociale ale scăderii în greutate
por: Maria, Ladea, et al.
Publicado: (2014)

An ALE meta-analytic review of musical expertise
por: Criscuolo, Antonio, et al.
Publicado: (2022)

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis
por: Scholtes, Rosalie A., et al.
Publicado: (2019)

Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
por: Schechter, Meir, et al.
Publicado: (2022)

Is the voice an auditory face? An ALE meta-analysis comparing vocal and facial emotion processing
por: Schirmer, Annett
Publicado: (2018)

Corrigendum: Brain networks of perceptual decision-making: an fMRI ALE meta-analysis
por: Keuken, Max C., et al.
Publicado: (2017)

An ALE Meta-Analysis of Specific Functional MRI Studies on Subcortical Vascular Cognitive Impairment
por: Xu, Wenwen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2nmuetlpddhonbeor3cc1r7eb4